Travere Therapeutics (TVTX) Operating Leases (2020 - 2026)
Travere Therapeutics' Operating Leases came in at $7.96 million for Q2 2026, down 43.6% from $14.12 million a year earlier and down 16.8% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Operating Leases (2020 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics' Operating Leases was $11.13 million, down 35.2% from FY2024.
- Operating Leases has declined in each of the last four years, with a five-year compound annual growth rate of -17.0% (FY2020 to FY2025).
- Going back by year, Operating Leases was $17.19 million in FY2024 (-24.0%), $22.61 million in FY2023 (-17.8%), $27.51 million in FY2022 (-12.7%) and $31.5 million in FY2021 (+11.2%).
- The Q2 2026 figure represents the lowest quarterly Operating Leases in data going back to Q4 2020.
- Year-over-year, Operating Leases has declined for 15 consecutive quarters, with an average decline of 31.4% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q4 2021 (growth of 11.2%), and the weakest in Q2 2026 (a decline of 43.6%).
- Business Quant data shows TVTX's Operating Leases at $9.57 million (Q1 2026), $11.13 million (Q4 2025) and $12.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Travere Therapeutics | 5.80 Bn | 5.40 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.96 Mn |
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | 11.13 Mn |
| Sep 30, 2025 | 12.65 Mn |
| Jun 30, 2025 | 14.12 Mn |
| Mar 31, 2025 | 15.58 Mn |
| Dec 31, 2024 | 17.19 Mn |
| Sep 30, 2024 | 18.58 Mn |
| Jun 30, 2024 | 19.94 Mn |
| Mar 31, 2024 | 21.29 Mn |
| Dec 31, 2023 | 22.61 Mn |
| Sep 30, 2023 | 23.86 Mn |
| Jun 30, 2023 | 25.11 Mn |
| Mar 31, 2023 | 26.33 Mn |
| Dec 31, 2022 | 27.51 Mn |
| Sep 30, 2022 | 28.27 Mn |
| Jun 30, 2022 | 29.36 Mn |
| Mar 31, 2022 | 30.44 Mn |
| Dec 31, 2021 | 31.50 Mn |
| Dec 31, 2020 | 28.34 Mn |
API Access
Travere Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();